Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas [Phase 1]
A Phase 1 trial of a combination chemotherapy regimen for patients with recurrent, refractory, or metastatic solid tumors and lymphomas has …
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J
Clinical trial update on the use of arsenic trioxide in young patients with leukemia or lymphoma treated on NCI-00-C-0070J.
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating vandetanib in combination with bevacizumab in adults with advanced solid tumors or lymphoma has complete…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas [Phase 1]
Phase 1 trial evaluating carboxyamidotriazole in combination with paclitaxel for advanced solid tumors and refractory lymphomas has complete…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer [Phase 2]
A Phase 2 trial evaluating umbilical cord blood transplantation for high-risk hematologic cancers has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma [Phase 1]
Phase 1 study of 17-DMAG in patients with advanced solid tumors or lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer [Phase 1]
Phase 1 study of ABT-888 (veliparib) in patients with refractory solid tumors or hematologic cancers conducted by NIH Clinical Center; the t…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy [Phase 1]
Phase 1 clinical trial update of CC-5013 (lenalidomide) in patients with cancer that did not respond to prior therapy; the study included ly…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
Phase 1 study evaluating MS-275 (entinostat) in patients with advanced solid tumors or lymphoma has been completed.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation
This completed clinical trial evaluated caregiver support and its effect on the quality of life of patients receiving donor bone marrow tran…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies [Phase 1]
Phase 1 trial assessing T-cell-depleted allogeneic stem cell transplantation after immunoablative induction chemotherapy and reduced-intensi…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma [Phase 1]
Phase 1 clinical trial evaluating Fenretinide Lym-X-Sorb in patients with recurrent or resistant solid tumors or lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Assessing the Effectiveness of Individual Education Plans for Childhood Cancer Survivors [NA]
A clinical trial update describing a study evaluating the effectiveness of individual education plans for childhood cancer survivors, involv…
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: Cognitive Functioning and Quality of Life in CNS Lymphoma
A completed clinical trial update reports on cognitive functioning and quality of life outcomes in patients with central nervous system lymp…
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer [Phase 1]
Phase 1 trial update for a vaccine therapy targeting Epstein-Barr virus–related cancers; the study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2012-02-13Clinical Trial Update: Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies [Phase 2]
Phase 2 trial evaluating rituximab added to BEAM-conditioned autologous stem cell transplantation for lymphoid malignancies. Results have be…
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating a busulfan plus melphalan conditioning regimen for lymphoid malignancies and multiple myeloma; the study c…
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS [Phase 2]
This Phase 2 trial studied selective T-cell depletion in stem cell transplantation to reduce graft-versus-host disease. It included patients…
-
CLINICAL_TRIALS trial_result · 2011-12-19Clinical Trial Update: Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies [Phase 1]
This update covers a Phase 1 trial of anti-third-party donor T lymphocytes with nonmyeloablative stem cell transplantation for indolent lymp…
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Non-Ablative Allo HSCT For Hematologic Malignancies or SAA [Phase 2]
Phase 2 trial update evaluating non-ablative allogeneic hematopoietic stem cell transplantation for hematologic malignancies and severe apla…
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Non-Myeloablative Allogeneic Stem Cell Transplantation [NA]
A completed clinical trial conducted at MD Anderson evaluated non-myeloablative allogeneic stem cell transplantation for lymphoma, with resu…
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
This Phase 2 clinical trial update reports on bone marrow transplantation as a treatment for hematologic cancers, including leukemia, lympho…
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of chemotherapy, radiation therapy, and biological therapy for hematologic cancers, with t…
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation [Phase 2]
This clinical trial update reports results from a Phase 2 study of lymphocyte infusion for patients who relapsed cancer after bone marrow or…
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation [Phase 3]
A Phase 3 clinical trial evaluating strategies to prevent graft-versus-host disease in patients undergoing bone marrow transplantation has c…